Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 81200-81479

Official Description

Molecular diagnostics; reverse transcription

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 83902 refers to a molecular diagnostic procedure known as reverse transcription. This technique involves extracting a molecular sequence from a tissue sample, which is crucial for analyzing genetic material. In reverse transcription, the typical flow of genetic information is reversed; this means that RNA is converted back into DNA. This process is essential for identifying specific sequences of nucleic acids, which can be indicative of genetic mutations associated with various diseases. The ability to detect these mutations is particularly valuable, as it allows for the identification of potential health issues even in the absence of overt symptoms. By utilizing this method, healthcare professionals can gain insights into a patient's genetic makeup, which can inform diagnosis and treatment strategies for conditions that may not yet be clinically apparent.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 83902 is indicated for various clinical scenarios where genetic analysis is necessary. The following conditions or situations may warrant the use of reverse transcription molecular diagnostics:

  • Detection of Genetic Mutations This procedure is performed to identify specific genetic mutations that may be present in a patient's tissue sample, which can be crucial for diagnosing certain diseases.
  • Asymptomatic Disease Screening It is particularly useful in cases where patients do not exhibit symptoms of a disease, allowing for early detection and intervention.
  • Genetic Research The technique can also be employed in research settings to study genetic variations and their implications in various health conditions.

2. Procedure

The procedure for CPT® Code 83902 involves several critical steps to ensure accurate molecular diagnostics through reverse transcription. Each step is essential for the successful extraction and analysis of genetic material.

  • Step 1: Sample Collection The first step involves obtaining a tissue sample from the patient. This sample is typically collected through a biopsy or other medical procedures that allow for the extraction of tissue for analysis.
  • Step 2: RNA Extraction Once the tissue sample is collected, the next step is to extract the RNA from the sample. This process requires careful handling to preserve the integrity of the RNA, as it is crucial for the subsequent steps of reverse transcription.
  • Step 3: Reverse Transcription In this step, the extracted RNA is subjected to reverse transcription, where it is converted back into complementary DNA (cDNA). This process is facilitated by the enzyme reverse transcriptase, which synthesizes DNA from the RNA template.
  • Step 4: Amplification and Analysis After the cDNA is synthesized, it may undergo amplification to increase the quantity of the genetic material for analysis. This amplification allows for more sensitive detection of specific nucleic acid sequences that may indicate genetic mutations.
  • Step 5: Interpretation of Results Finally, the results of the molecular analysis are interpreted by qualified professionals. This interpretation is critical for determining the presence of genetic mutations and their potential implications for the patient's health.

3. Post-Procedure

Post-procedure care following the molecular diagnostics associated with CPT® Code 83902 typically involves monitoring the patient for any immediate reactions to the tissue sampling process. Additionally, healthcare providers will review the results of the genetic analysis with the patient, discussing any identified mutations and their potential impact on health. Follow-up appointments may be scheduled to further evaluate the patient's condition and to discuss possible treatment options based on the findings. It is also important for healthcare professionals to document the results and any recommendations for further testing or interventions as necessary.

Short Descr MOLECULAR DIAGNOSTICS
Medium Descr MOLECULAR DIAGNOSTICS
Long Descr Molecular diagnostics; reverse transcription
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Discontinued Code
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2013-01-01 Deleted Code deleted, see 81200-81479
2013-01-01 Changed Short and Medium Descriptors changed.
1997-01-01 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"